Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

ClinicalTrials.gov ID: NCT00003725

Public ClinicalTrials.gov record NCT00003725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Randomized Study of a Single Adjunctive Instillation of Intravesical AD 32 (N-Trifluoroacetyladriamycin-14-valerate) Versus No Adjunctive Therapy Immediately Following Transurethral Resection in Patients With Multiple Superficial (Ta/T1) Bladder Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Transurethral resection is a less invasive type of surgery for bladder cancer and may have fewer side effects and improve recovery. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether transurethral resection plus AD 32 is more effective than transurethral resection alone for bladder cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of transurethral resection surgery followed by AD 32 with that of transurethral resection alone in treating patients who have newly diagnosed or recurrent bladder cancer.

Study identification

NCT ID
NCT00003725
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Anthra Pharmaceuticals
Industry
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1996 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Nov 6, 2013

Started 1996

United States locations

U.S. sites
51
U.S. states
28
U.S. cities
46
Facility City State ZIP Site status
Urology Associates Birmingham Alabama 35205 —
Urology Associates, Ltd. Phoenix Arizona 85012 —
University of California San Diego Cancer Center La Jolla California 92093-0658 —
San Diego Urology Center La Mesa California 91942 —
Hillcrest Urological Medical Group San Diego California 92103 —
San Diego Urology Center San Diego California 92120 —
UCSF Cancer Center and Cancer Research Institute San Francisco California 94115-0128 —
Santa Monica Urologic Medical Group Santa Monica California 90404 —
Western Urological Associates Van Nuys California 91405 —
Urology Specialists, P.C. Waterbury Connecticut 06708 —
George Washington University Hospital Washington D.C. District of Columbia 20037 —
Atlantic Urological Associates Daytona Beach Florida 32114 —
University of Florida - Gainesville Gainesville Florida 32610-0277 —
Sylvester Cancer Center, University of Miami Miami Florida 33136 —
Urology Care - South Miami Florida 33173 —
Urology Health Center New Port Richey Florida 34652 —
Office of Ira W. Klimberg Ocala Florida 32674 —
Urology Treatment Center Sarasota Florida 3429 —
Georgia Urology Atlanta Georgia 30342 —
Affliated Urology Chicago Illinois 60612 —
University of Chicago Cancer Research Center Chicago Illinois 60637 —
Evanston Northwestern Healthcare Evanston Illinois 60201 —
Clinic of Urologic Wellness Lexington Kentucky 40509 —
Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana 71130-3932 —
Cambridge Urological Associates, Inc. Cambridge Massachusetts 02238 —
Michigan Institute of Urology Detroit Michigan 48236 —
Mississippi Urology Clinic, P.A. Jackson Mississippi 39202 —
Urology Center Omaha Nebraska 68122 —
Sheldon Freedman Ltd. Las Vegas Nevada 89109 —
Desert Urology North Las Vegas Nevada 89128 —
Norris Cotton Cancer Center Lebanon New Hampshire 03756 —
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095 —
Office of John Byrne New Rochelle New York 10801 —
Mount Sinai Medical Center, NY New York New York 10029 —
Herbert Irving Comprehensive Cancer Center New York New York 10032 —
Wake Urological Associates Raleigh North Carolina 27607 —
Department of Urology and Urologic Oncology Columbus Ohio 43210 —
Oregon Cancer Center at Oregon Health Sciences University Portland Oregon 97201-3098 —
Urology Clinic, P.C. Portland Oregon 97210 —
Office of Jeffrey K. Cohen Pittsburgh Pennsylvania 15222 —
Veterans Affairs Medical Center - Memphis Memphis Tennessee 38104 —
Vanderbilt Cancer Center Nashville Tennessee 37232-6838 —
Urology Associates of North Texas Arlington Texas 76015 —
Baylor College of Medicine Houston Texas 77030 —
Wilford Hall - 59th Medical Wing Lackland Air Force Base Texas 78236-5300 —
Veterans Affairs Medical Center - Temple Temple Texas 76504 —
Huntsman Cancer Institute Salt Lake City Utah 84132 —
Sentara Cancer Center Norfolk Virginia 23507 —
Virginia Urology Center Richmond Virginia 23230 —
Office of Ronald G. Anderson Tacoma Washington 98405 —
West Virginia University Hospitals Morgantown West Virginia 26506-9162 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003725 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →